Michelle Xia is the cofounder, chairwoman and CEO of China-based biotech firm Akeso, which has multiple approved drugs in China to treat cancer.⁣ ⁣ Akeso has captured attention in the biotech world because one of its drugs outperformed Merck's bestseller Keytruda in a head to head Phase 3 trial in 2024.⁣ ⁣ See where she lands on the 2026 #ForbesBillionaires list at the link in our bio. (Photo: Akeso)